AFIB · As filed with the SEC

Acutus Medical balance sheet, by fiscal year

The statement as Acutus Medical presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.

Consolidated Balance Sheets · USD thousands

USD thousands	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019
ASSETS
Current assets:
Cash and cash equivalents	14,019	19,170	25,584	24,071	25,234	9,452
Marketable securities, short-term	—	—	44,863	76,702	105,839	62,351
Marketable securities, short-term	0	3,233	—	—	—	—
Restricted cash, short-term	0	7,030	5,764	150	150	150
Accounts receivable	7,878	11,353	21,085	3,633	2,160	263
Inventory	1,790	4,278	13,327	16,408	12,958	8,424
Employer retention credit receivable	—	—	4,703	—	—	—
Employer retention credit receivable	—	0	—	—	—	—
Prepaid expenses and other current assets	641	678	2,541	5,326	5,047	1,816
Current assets of discontinued operations (Note 3)	1,250	510	—	—	—	—
Total current assets	25,578	46,252	117,867	126,290	151,388	82,456
Marketable securities, long-term	—	—	0	7,120	8,726	—
Noncurrent assets
Property and equipment, net	517	825	9,221	13,670	12,356	4,427
Right-of-use assets, net	2,459	3,189	3,872	4,521	1,669	2,341
Intangible assets, net	—	—	1,583	5,013	5,653	4,110
Goodwill	—	—	0	12,026	12,026	12,026
Other assets	94	94	897	1,152	717	95
Non-current assets of discontinued operations (Note 3)	0	3,600	—	—	—	—
Total assets	28,648	53,960	133,440	169,792	192,535	105,455
LIABILITIES AND STOCKHOLDERS' (DEFICIT) EQUITY
Current liabilities:
Accounts payable	1,276	2,761	4,721	7,519	8,266	3,882
Accrued liabilities	3,006	2,887	9,686	9,096	7,308	10,076
Contingent consideration, short-term	—	—	1,800	1,500	5,400	8,200
Contingent consideration, short-term	—	0	—	—	—	—
Operating lease liabilities, short-term	957	718	319	395	933	833
Common and preferred stock warrant liability	—	—	—	—	—	8,919,000
Long-term debt, current portion	7,005	1,864	—	—	—	—
Warrant liability	194	409	3,346	—	—	—
Current liabilities of discontinued operations (Note 3)	0	10,303	—	—	—	—
Total current liabilities	12,438	18,942	19,872	18,510	21,907	31,910
Operating lease liabilities, long-term	2,238	3,243	4,103	4,591	1,134	2,054
Long-term debt	25,564	32,654	34,434	40,415	39,011	38,244
Contingent consideration, long-term	—	—	0	500	3,900	5,700
Other long-term liabilities	—	0	12	50	—	—
Total liabilities	40,240	54,839	58,421	64,066	65,952	77,908
Series A Convertible Preferred Stock	—	—	—	—	—	3,059,000
Series B Convertible Preferred Stock	—	—	—	—	—	40,685,000
Series C Convertible Preferred Stock	—	—	—	—	—	74,575,000
Series D Convertible Preferred Stock	—	—	—	—	—	135,039,000
Stockholders' (deficit) equity
Preferred stock, $0.001 par value; 5,000,000 shares authorized as of December 31, 2024 and December 31, 2023; 6,666 shares of the preferred stock, designated as Series A Common Equivalent Preferred Stock, are issued and outstanding as of December 31, 2024 and December 31, 2023, respectively	0	0	0	0	—	—
Common stock, $0.001 par value; 260,000,000 shares authorized as of December 31, 2024 and December 31, 2023; 29,912,305 and 29,313,667 shares issued and outstanding as of December 31, 2024 and December 31, 2023, respectively	30	29	29	28	28	1
Additional paid-in capital	598,670	599,935	594,173	584,613	487,290	33,252
Accumulated deficit	(609,524)	(599,977)	(518,314)	(478,698)	(361,015)	(259,034)
Accumulated other comprehensive loss	(768)	(866)	(869)	(217)	280	(30)
Total stockholders' equity	—	—	75,019	105,726	126,583	(225,811)
Total stockholders' deficit	(11,592)	(879)	—	—	—	—
Total liabilities and stockholders' deficit	28,648	53,960	133,440	169,792	192,535	105,455

As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.